2000
DOI: 10.1034/j.1398-9995.2000.00649.x
|View full text |Cite
|
Sign up to set email alerts
|

Clinical and pathologic methods to assess the long‐term safety of nasal corticosteroids

Abstract: These results clearly indicate that long-term treatment with TAA has no atrophic effect on nasal mucosa.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
26
0

Year Published

2000
2000
2019
2019

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 37 publications
(26 citation statements)
references
References 17 publications
(12 reference statements)
0
26
0
Order By: Relevance
“…Moreover, epithelial cell metaplasia has been observed in the nasal biopsies of some patients suffering from perennial rhinitis (813,814). Although the nasal and bronchial mucosa are exposed to the same noxious environment (and even more so the nose), epithelial shedding is more pronounced in the bronchi than in the nose of the same patients suffering from asthma and rhinitis (19,815).…”
Section: Allergic Inflammationmentioning
confidence: 90%
See 1 more Smart Citation
“…Moreover, epithelial cell metaplasia has been observed in the nasal biopsies of some patients suffering from perennial rhinitis (813,814). Although the nasal and bronchial mucosa are exposed to the same noxious environment (and even more so the nose), epithelial shedding is more pronounced in the bronchi than in the nose of the same patients suffering from asthma and rhinitis (19,815).…”
Section: Allergic Inflammationmentioning
confidence: 90%
“…However, there are differences in safety between molecules, those with low bioavailability being the best tolerated (1573,1574). The current intranasal preparations are well tolerated and can be used on a long-term basis without atrophy of the mucosa (814,1508). Evidence shows that the long-term use of intranasal glucocorticosteroids is free of the concerns associated with the long-term use of oral glucocorticosteroids.…”
Section: Intranasal Glucocorticosteroidsmentioning
confidence: 99%
“…These findings provide further evidence that the intrinsic nasal protective effects, including the nasal mucus barrier function, the mucus diluting effect of the nasal medication, and the effect of mucus pH on nasal drug activity, can compensate in vivo for toxic effects observed with these drugs in vitro. In fact, a number of studies have corroborated the preservation or even improvement of nasal mucosa structure after long-term administration of these intranasal sprays [14,15]. Indeed, some studies have addressed the long-term or short-term effect of certain intranasal steroids on ciliary function in allergic rhinitis patients, by assessing indigocarmine saccharine or radiotracer clearance from the nose as indicators of CBF, and demonstrated no significant impairment of mucociliary function [16,17].…”
Section: Discussionmentioning
confidence: 99%
“…Although the epithelialmesenchymal trophic unit seems to be functional in rhinitis (61), epithelial damage is only minimal (62)(63)(64) and the reticular basement membrane does not appear to be largely pseudo-thickened (65). Moreover, the demonstration of fibrogenic growth factors in the nasal mucosa of patients with allergic rhinitis is lacking, due in part to the paucity of studies.…”
Section: Nasal Remodeling In Rhinitismentioning
confidence: 99%